Drug Store News12d
Sanofi nears selling 50% controlling stake in Opella to CD&R
Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton ...
pharmaphorum5y
Sanofi licenses OTC Tamiflu rights for the US market
Tamiflu was a blockbuster product for Roche over a ... Tamiflu has been approved in New Zealand as an OTC drug since 2007, and that will likely assist Sanofi as it tries to persuade the FDA ...
Hosted on MSN1mon
Sanofi says FDA lifted clinical hold on trial for Cialis OTC switch
Sanofi’s (NASDAQ:SNY ... switch of Cialis tablets from a prescription-only medicine to an over-the-counter product. The company added that it is finalizing the clinical and regulatory work ...
pharmaphorum1d
GSK, Sanofi and Haleon 'facing billions of dollars in Zantac liability'
Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...
High-Yield Alert! Massive Rs 55 Final Dividend Declared; Watch For A Breakout Or Breakdown?
Subject to shareholder approval at the subsequent Annual General Meeting (AGM), the Board of Directors of Sanofi Consumer ...